The value proposition of Xeljanz rests with the availability of oral. That's it. Not the efficacy without the 10mg. Never going to be the safety or the AEs. It's the oral. Why then, are you guys waiting so long to frame value in messages to the public? When the general public realizes that there's a oral option available, only then will your product humm. So, when can we expect it?
Don't know where you got your numbers from, we're not at goal, but we're closer to 40 million. We still got a chance at Hawaii (NOT)